Literature DB >> 20149443

PEG-PLA microparticles for encapsulation and delivery of Tat-EGFP to retinal cells.

Mehrdad Rafat1, Carolyne A Cléroux, Wai Gin Fong, Adam N Baker, Brian C Leonard, Michael D O'Connor, Catherine Tsilfidis.   

Abstract

The efficient and controlled delivery of genes and proteins to retinal cells remains a challenge. In this study, we evaluated polyethylene glycol-polylactic acid (PEG-PLA) microparticles for encapsulation and delivery of a Transactivator of transcription-enhanced green fluorescent protein fusion (Tat-EGFP) to retinal cells. Our main objective was to develop a microparticle system that delivers Tat-EGFP with an initial rapid release (within 24 h) followed by a sustained release. We prepared four different formulations of Tat-EGFP encapsulated PEG-PLA particles to investigate the effects of protein and polymer concentrations on particle morphology and protein release, using scanning electron microscopy (SEM) and fluorometry techniques. The optimum formulation was selected based on higher protein release, and smaller particle size. The optimum formulation was then tested in vitro for cell biocompatibility and protein internalization, and in vivo for cellular toxicity following sub-retinal injections into rat eyes. The results suggest that PEG-PLA microparticles can deliver proteins in cell culture allowing protein internalization in as little as 1 h. In vivo, protein was shown to localize within the photoreceptor layer of the retina, and persist for at least 9 weeks with no observed toxicity. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20149443     DOI: 10.1016/j.biomaterials.2010.01.031

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

1.  Overexpression of the X-Linked Inhibitor of Apoptosis Protects Against Retinal Degeneration in a Feline Model of Retinal Detachment.

Authors:  Sarah J Wassmer; Brian C Leonard; Stuart G Coupland; Adam N Baker; John Hamilton; William W Hauswirth; Catherine Tsilfidis
Journal:  Hum Gene Ther       Date:  2017-03-23       Impact factor: 5.695

Review 2.  Nanoparticle PEGylation for imaging and therapy.

Authors:  Jesse V Jokerst; Tatsiana Lobovkina; Richard N Zare; Sanjiv S Gambhir
Journal:  Nanomedicine (Lond)       Date:  2011-06       Impact factor: 5.307

Review 3.  Polymeric vectors for ocular gene delivery.

Authors:  Viral Tamboli; Gyan P Mishra; Ashim K Mitrat
Journal:  Ther Deliv       Date:  2011-04

4.  Intravitreal Poly(L-lactide) Microparticles Sustain Retinal and Choroidal Delivery of TG-0054, a Hydrophilic Drug Intended for Neovascular Diseases.

Authors:  Namdev B Shelke; Rajendra Kadam; Puneet Tyagi; Vidhya R Rao; Uday B Kompella
Journal:  Drug Deliv Transl Res       Date:  2011-02       Impact factor: 4.617

Review 5.  Recent advances in PEG-PLA block copolymer nanoparticles.

Authors:  Ren Zhong Xiao; Zhao Wu Zeng; Guang Lin Zhou; Jun Jie Wang; Fan Zhu Li; An Ming Wang
Journal:  Int J Nanomedicine       Date:  2010-11-26

6.  Enhanced green fluorescent protein-mediated synthesis of biocompatible graphene.

Authors:  Sangiliyandi Gurunathan; Jae Woong Han; Eunsu Kim; Deug-Nam Kwon; Jin-Ki Park; Jin-Hoi Kim
Journal:  J Nanobiotechnology       Date:  2014-10-03       Impact factor: 10.435

Review 7.  Poly(Lactic Acid)-Based Microparticles for Drug Delivery Applications: An Overview of Recent Advances.

Authors:  Antonios Vlachopoulos; Georgia Karlioti; Evangelia Balla; Vasileios Daniilidis; Theocharis Kalamas; Myrika Stefanidou; Nikolaos D Bikiaris; Evi Christodoulou; Ioanna Koumentakou; Evangelos Karavas; Dimitrios N Bikiaris
Journal:  Pharmaceutics       Date:  2022-02-04       Impact factor: 6.321

8.  Encapsulation of Amikacin into Microparticles Based on Low-Molecular-Weight Poly(lactic acid) and Poly(lactic acid-co-polyethylene glycol).

Authors:  Marta Glinka; Katerina Filatova; Justyna Kucińska-Lipka; Eva Domincova Bergerova; Andrzej Wasik; Vladimir Sedlařík
Journal:  Mol Pharm       Date:  2021-07-01       Impact factor: 4.939

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.